Issue areas declared on the filings, ranked by how many filings name each one.
Medical/Disease Research/Clinical Labs
MED · 50 clients
309 filings
$3.9M on those filings
Health Issues
HCR · 30 clients
186 filings
$5.4M on those filings
Budget/Appropriations
Who does the lobbying
Every lobbyist named on this registrant's filings.
Darin L GardnerCovered position: Legislative Correspondent Senator Tim Hutchinson; Research Assistant Senate HELP Committee; Chief of Staff Kay Granger254 filings30 clients · through 2026
Julie P. Pawelczyk253 filings35 clients · through 2026
William A. Franco141 filings17 clients · through 2025
Stephen R Conafay132 filings19 clients · through 2026
Josh NarrowCovered position: Intern Senator Casey105 filings
Foreign interests disclosed
Every foreign entity named on this registrant's filings.
Mitsubishi Tanabe Pharma Corportation
Japan
3 filings
through 2014
Genetic Analysis
Norway
2 filings
through 2021
Bio-Me
The filings
The 20 most recent of 600 filings. Every figure above is built from these records.
This record groups every filed spelling of the registrant's name into one entity, so punctuation variants of the same firm read as one. The grouping is the registrant's normalized name — firms that file under genuinely different names appear separately. Handle: the-conafay-group-llc.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Reading this · An LD-2 reports either a fee the registrant charged or expenses it spent, never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. The expenses basis is what an organization lobbying on its own behalf files — usually for itself, sometimes for an affiliate under a different name — so a name on the second list is the client the filing names, not necessarily a claim that the registrant lobbied for someone else's account. Across every relationship on file — not just those shown — this registrant reported $9.6M in fees and $0 in expenses.
BUD · 24 clients
155 filings
$1.8M on those filings
Medicare/Medicaid
MMM · 6 clients
58 filings
$1.2M on those filings
Manufacturing
MAN · 6 clients
20 filings
$270K on those filings
Defense
DEF · 4 clients
12 filings
$290K on those filings
Disaster Planning/Emergencies
DIS · 1 client
7 filings
$230K on those filings
Science/Technology
SCI · 3 clients
5 filings
$73K on those filings
Pharmacy
PHA · 1 client
3 filings
$70K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore money on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
12 clients · through 2026
Bryan ShuyCovered position: Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmteon Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst.Secretary for Preparedness and Response (ASPR)71 filings14 clients · through 2026
Kristen Lafayette63 filings7 clients · through 2026
Hannah Baer24 filings3 clients · through 2021
Evangeline Smith23 filings4 clients · through 2026
Elizabeth Barrows13 filings3 clients · through 2013
Melissa Dupree12 filings5 clients · through 2014
Michael Salgaller8 filings3 clients · through 2015
Patrick J. Plues8 filings4 clients · through 2013
Brian Tse6 filings3 clients · through 2026
Aishat Magbade6 filings2 clients · through 2022
Yasmine Alexis Sadoudi4 filings1 client · through 2023
WENDY SHELTON dvm3 filings1 client · through 2015
Gaylon Morris2 filings1 client · through 2014
Covered positions · 4 of 20 lobbyists named on these filings disclosed a prior government post. A covered official position is the LD-2 field a lobbyist uses to report having held one; the text is reproduced exactly as filed.
Norway
1 filing
through 2023
Vaxxas Pty Ltd
Australia
1 filing
through 2022
Microba Life Sciences
Australia
1 filing
through 2021
Servatus Biopharmaceuticals
Australia
1 filing
through 2021
Mallinckrodt Pharmaceuticals, LLC
United Kingdom
1 filing
through 2020
Roivant Sciences Gmbh
Switzerland
1 filing
through 2020
Roivant Sciences Holdings Ltd
United Kingdom
1 filing
through 2020
Roivant Sciences Ltd
Bermuda
1 filing
through 2020
Chiesi Farmaceutici S.P.A.
Italy
1 filing
through 2018
Philip Morris Investments B.V.
Netherlands
1 filing
through 2013
What this discloses · An LD-2 reports foreign entities that hold an interest in, or contribute to, the client — so these are foreign interests behind the organizations this registrant files for, not owners of the registrant itself. Disclosure is a reporting requirement, not an allegation.
